390 related articles for article (PubMed ID: 23845207)
1. B-cell activating factor genetic variants in lymphomagenesis associated with primary Sjogren's syndrome.
Nezos A; Papageorgiou A; Fragoulis G; Ioakeimidis D; Koutsilieris M; Tzioufas AG; Moutsopoulos HM; Voulgarelis M; Mavragani CP
J Autoimmun; 2014 Jun; 51():89-98. PubMed ID: 23845207
[TBL] [Abstract][Full Text] [Related]
2. Associations between TNFSF13B polymorphisms and primary Sjögren's syndrome susceptibility in primary Sjögren's syndrome patients: A meta-analysis.
Zheng A; Hu N; Xu J; Yuan Y; Zhang S; Chen W; Bai Y; Sun H
Immun Inflamm Dis; 2023 Dec; 11(12):e1103. PubMed ID: 38156381
[TBL] [Abstract][Full Text] [Related]
3. Polymorphism in the 5' regulatory region of the B-lymphocyte activating factor gene is associated with the Ro/La autoantibody response and serum BAFF levels in primary Sjogren's syndrome.
Nossent JC; Lester S; Zahra D; Mackay CR; Rischmueller M
Rheumatology (Oxford); 2008 Sep; 47(9):1311-6. PubMed ID: 18617551
[TBL] [Abstract][Full Text] [Related]
4. Genetic Variants of the
Flessa CM; Zampeli E; Evangelopoulos ME; Natsis V; Bodewes ILA; Huijser E; Versnel MA; Moutsopoulos HM; Mavragani CP
Front Immunol; 2022; 13():836824. PubMed ID: 35371038
[TBL] [Abstract][Full Text] [Related]
5. Subclinical atherosclerosis profiles in rheumatoid arthritis and primary Sjögren's syndrome: the impact of BAFF genetic variations.
Kintrilis N; Gravani F; Rapti A; Papaioannou M; Flessa CM; Nezos A; Antypa E; Papadaki I; Karageorgas Τ; Moutsopoulos HM; Mavragani CP
Rheumatology (Oxford); 2023 Feb; 62(2):958-968. PubMed ID: 35689637
[TBL] [Abstract][Full Text] [Related]
6. No evidence for an association between the -871 T/C promoter polymorphism in the B-cell-activating factor gene and primary Sjögren's syndrome.
Gottenberg JE; Sellam J; Ittah M; Lavie F; Proust A; Zouali H; Sordet C; Sibilia J; Kimberly RP; Mariette X; Miceli-Richard C
Arthritis Res Ther; 2006; 8(1):R30. PubMed ID: 16507129
[TBL] [Abstract][Full Text] [Related]
7. B-cell activating factor and related genetic variants in lupus related atherosclerosis.
Theodorou E; Nezos A; Antypa E; Ioakeimidis D; Koutsilieris M; Tektonidou M; Moutsopoulos HM; Mavragani CP
J Autoimmun; 2018 Aug; 92():87-92. PubMed ID: 29859654
[TBL] [Abstract][Full Text] [Related]
8. Analysis of TNFSF13B polymorphisms and BAFF expression in rheumatoid arthritis and primary Sjögren's syndrome patients.
Santillán-López E; Muñoz-Valle JF; Oregon-Romero E; Espinoza-García N; Treviño-Talavera BA; Salazar-Camarena DC; Marín-Rosales M; Cruz A; Alvarez-Gómez JA; Sagrero-Fabela N; Cerpa-Cruz S; Palafox-Sánchez CA
Mol Genet Genomic Med; 2022 Jun; 10(6):e1950. PubMed ID: 35411715
[TBL] [Abstract][Full Text] [Related]
9. TREX1 variants in Sjogren's syndrome related lymphomagenesis.
Nezos A; Makri P; Gandolfo S; De Vita S; Voulgarelis M; Crow MK; Mavragani CP
Cytokine; 2020 Aug; 132():154781. PubMed ID: 31326279
[TBL] [Abstract][Full Text] [Related]
10. MTHFR gene variants and non-MALT lymphoma development in primary Sjogren's syndrome.
Fragkioudaki S; Nezos A; Souliotis VL; Chatziandreou I; Saetta AA; Drakoulis N; Tzioufas AG; Voulgarelis M; Sfikakis PP; Koutsilieris M; Crow MK; Moutsopoulos HM; Mavragani CP
Sci Rep; 2017 Aug; 7(1):7354. PubMed ID: 28779180
[TBL] [Abstract][Full Text] [Related]
11. Association of genetic variation in B-cell activating factor with chronic hepatitis B virus infection.
Han Q; Yang C; Li N; Li F; Sang J; Lv Y; Zhao W; Li C; Liu Z
Immunol Lett; 2017 Aug; 188():53-58. PubMed ID: 28627389
[TBL] [Abstract][Full Text] [Related]
12. A BAFF receptor His159Tyr mutation in Sjögren's syndrome-related lymphoproliferation.
Papageorgiou A; Mavragani CP; Nezos A; Zintzaras E; Quartuccio L; De Vita S; Koutsilieris M; Tzioufas AG; Moutsopoulos HM; Voulgarelis M
Arthritis Rheumatol; 2015 Oct; 67(10):2732-41. PubMed ID: 26097183
[TBL] [Abstract][Full Text] [Related]
13. Genetic associations to germinal centre formation in primary Sjogren's syndrome.
Reksten TR; Johnsen SJ; Jonsson MV; Omdal R; Brun JG; Theander E; Eriksson P; Wahren-Herlenius M; Jonsson R; Nordmark G
Ann Rheum Dis; 2014 Jun; 73(6):1253-8. PubMed ID: 23606706
[TBL] [Abstract][Full Text] [Related]
14. B-cell activating factor of the tumour necrosis factor family expression in blood monocytes and T cells from patients with primary Sjögren's syndrome.
Lavie F; Miceli-Richard C; Ittah M; Sellam J; Gottenberg JE; Mariette X
Scand J Immunol; 2008 Feb; 67(2):185-92. PubMed ID: 18201372
[TBL] [Abstract][Full Text] [Related]
15. IL-14α as a Putative Biomarker for Stratification of Dry Eye in Primary Sjögren's Syndrome.
Liang Y; Xian Z; Fu D; Liu S; Yao Y; Jin Y; Gao C; Shen L; Shi G; He J
Front Immunol; 2021; 12():673658. PubMed ID: 34012457
[TBL] [Abstract][Full Text] [Related]
16. Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjögren's syndrome.
Lavie F; Miceli-Richard C; Quillard J; Roux S; Leclerc P; Mariette X
J Pathol; 2004 Apr; 202(4):496-502. PubMed ID: 15095277
[TBL] [Abstract][Full Text] [Related]
17. Contribution of Genetic Factors to Sjögren's Syndrome and Sjögren's Syndrome Related Lymphomagenesis.
Nezos A; Mavragani CP
J Immunol Res; 2015; 2015():754825. PubMed ID: 26550578
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers of lymphoma in Sjögren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study.
Quartuccio L; Isola M; Baldini C; Priori R; Bartoloni Bocci E; Carubbi F; Maset M; Gregoraci G; Della Mea V; Salvin S; De Marchi G; Luciano N; Colafrancesco S; Alunno A; Giacomelli R; Gerli R; Valesini G; Bombardieri S; De Vita S
J Autoimmun; 2014 Jun; 51():75-80. PubMed ID: 24231556
[TBL] [Abstract][Full Text] [Related]
19. B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome.
Ittah M; Miceli-Richard C; Eric Gottenberg J; Lavie F; Lazure T; Ba N; Sellam J; Lepajolec C; Mariette X
Arthritis Res Ther; 2006; 8(2):R51. PubMed ID: 16507175
[TBL] [Abstract][Full Text] [Related]
20. FAS -670A>G promoter polymorphism is associated with soluble Fas levels in primary Sjögren's syndrome.
Treviño-Talavera BA; Palafox-Sánchez CA; Muñoz-Valle JF; Orozco-Barocio G; Navarro-Hernández RE; Vázquez-Del Mercado M; García de la Torre I; Oregon-Romero E
Genet Mol Res; 2014 Jul; 13(3):4831-8. PubMed ID: 25062418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
